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LONGEVITY – CAN WE AFFORD IT?
THE PROBLEM OF HOUSEHOLDS’ DIRECT 
HEALTH CARE EXPENDITURES IN POLAND
INTRODUCTION
Longevity can be defined as a long individual lifespan or as population aging. 
The latter is a resultant of various demographic tendencies, including: the former 
longevity – increasing life expectancy, as well as decreasing fertility. These factors 
result in the growing share of elderly persons and the age median in the population. 
We observe rising longevity, expressed according to both connotations, overall in the 
world. Children born in 2014 are expected to live on average (CIA 2014):
– up to almost 90 years in Monaco (the highest value),
– slightly less than 85 years in Macau, Japan, and Singapore,
– less than 76 years in Poland (which ranks 76th in the world),
– under 50 years in Guinea-Bissau, South Africa, and Chad (the lowest values).
These projections show that, on the one hand, longevity is becoming a fact in 
most developed countries, while on the other hand, disparities in life expectancy 
are still considerable across the globe. A longer life can be attributed to the modern 
lifestyle, advances in medicine, knowledge and technology, social policies as well 
as the transfer of information over the Internet. These factors allow people to avoid, 
eliminate, diagnose, and cure an increasing number of diseases. They also contribute 
to improving people’s quality of life and health care and, therefore, their health 
itself, which determines life expectancy.
Over the decades, the human lifespan has lengthened. However, breakthroughs in 
life-saving and life-expanding sciences do not go hand in hand with health improving 
progress. We will probably live longer than our ancestors, but the advanced stages of 
life may not be as comfortable and dignified as one would wish. Moreover, individual 
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longevity is often accompanied by the process of population ageing. The populations 
of the most developed countries are ageing rapidly as the age median and the share 
of the elderly in the population continue to increase, which weighs heavily on labour 
markets, health care systems, public budgets, family structures, and social roles, as 
well as on many other social, economic, and cultural aspects on the micro and macro 
levels. This entails the need for important changes in social policy.
The two types of longevity, measured at the individual and the population level, 
together with the age-induced deterioration of health influence the level of public 
health care expenditures. In USA the elderly population increased by 13 million 
between 1966 and 1998, while public medical expenses of Medicare program for 
acute help to the elderly rose from 0.6% of GDP to 2.3% in 1999. The research by 
Lubitz et al. (2001) shows that public and private indirect health care expenditures 
for the elderly population increased at a greater rate than expenditures for the group 
under age 65. Still, however, the public expenditures are not sufficient to cover the 
medical needs of the elderly or those of the rest of the population, which entails 
a consistent increase in private direct expenses paid by households.
Increasing longevity may or may not directly stimulate additional medical 
expenditures, total and per capita. Studies have not been unanimous or unequivocal 
on that question. However, it is reasonable to assume that with older age, health 
status deteriorates and that the elderly demand more extensive health care and more 
pharmaceuticals than young adults. In this context several studies focusing primarily 
on the group of elderly have been carried out. Sole-Auro et al. (2012) analysed the 
differences between public expenditures for native and immigrant elderly people 
and found that socio-economic variables influence medical habits and needs. Meara 
et al. (2004) indicated that medical expenses tend to increase over time, however, 
important differences across age groups can be noticed. It is reasonable to expect 
that the level of medical expenditures differ between the elderly and non-elderly. On 
the one hand, the elderly are likely to use more services. On the other hand, some 
empirical evidence indicates that the health (especially concerning disability) of the 
elderly is improving while deteriorating among the non-elderly. Consequently, the 
causal relationships between determinants of health status may be varying among 
the age groups.
The aim of this paper is to verify (using theoretical and empirical tools) the 
existence and the level of the longevity cost. This paper is an attempt to test three 
hypotheses: (1) the medical expenditures increase with longevity, (2) households of 
the elderly spend more on health than others, (3) determinants of private direct medical 
expenses differ between households of the elderly and the others. To verify this, first, 
the demographic analysis is used to present the long-term tendencies in the process 
of population ageing. Secondly, the literature review examines the socio-economic 
costs of longevity in the macroscale. Third, a statistical analysis on a representative 
sample of Polish households is performed in order to verify the differences in health 
care spendings between the elderly and the non-elderly. Finally, a microeconometric 
29
Longevity – can we afford it?…
model is used to estimate the influence of selected socio-economic variables on 
the value of households’ direct health care expenditures in Poland. This research 
is carried out for the years 2003 and 2013 to determine whether the factors are 
stable over time, and for the group of elderly and non-elderly in order to identify 
possible similarities and differences between these two demographic groups. The 
empirical part is focused on the out-of-pocket expenses on the health care, that is, 
not reimbursed by the public insurance. Since the health care system in Poland is 
mainly publicly funded (approx. 70% of all health care costs) and private indirect 
expenditures constitute marginal part (less than 5%) of the total expenditures on the 
health care, the level of direct households’ input is considerable (around 30% of 
total expenditures). Studying direct private expenses on the health care is important 
for two main reasons. First, they constitute a significant financial burden on the 
household budget and, unlike other sources of health care expenses (covered by 
the public or private insurance), they do not create the illusion of “free-of-charge” 
services. Second, high share of the out-of-pocket expenses in the Polish health care 
financing structure may serve as an indicator of the efficiency (in a broad sense) of 
the whole medical system and the health care policies.
THE PROCESS OF POPULATION AGEING
Over the last decades life expectancy at birth has been increasing in most 
developed and developing countries. Data for selected countries (Fig. 1) suggest 
that the increase over last 50 years was from 1.7 years (Ukraine) to 31 years (China), 
while in the European Union (EU) from 5.8 years (Slovak Republic) to 16.4 years 
(Portugal). The percentage change in life expectancy over the last half century 
reached 50% in Turkey, 59% in India, and 70% in China. In Europe the relative 
change of life expectancy was the highest for Portugal – 25%.
Figure 1. Life expectancy at birth, selected countries, 1962 and 2012
Source: own elaboration based on OECD and Worldbank database (2017).
30
Agata Żółtaszek
The average length of life in the USA increased from the 1900s to the 1980s by 
almost 30 years. This is mostly the result of eliminating premature deaths (that is, 
occurring in age lower than the life expectancy). In fact, the hazardous impact of 
chronical diseases, which are the main causes of premature deaths, may be postponed 
due to advancement in medicine. The latter compresses the period spent in a bad 
health to the last years of life.
Increasing life expectancy contributes to the process of population ageing, 
defined as the growing proportion of the elderly or as increasing median age in 
a population. Over the last half of century, the proportion of elderly people, that 
is aged 65 and over, considerably increased. In some countries, such as Bulgaria, 
Finland, and Portugal, the increase reached 140%. At the same time, the percentage 
of people older than 80 doubled in some states (such as Bulgaria, Czech Republic, 
Germany, Greece, Hungary, the Netherlands, Slovakia, and Switzerland), tripled 
in others (Spain, Italy, and Portugal) and even quadrupled (Finland) (Fig. 2). In 
Europe, the median age increased by 4.3 years in the UK (from 35.5 in 1962 to 
39.7 in 2012), 14.1 years in Portugal (from 28 in 1962 to 42.1 in 2012), 13.9 years 
in Liechtenstein (from 27.7 in 1962 to 41.6 in 2012), and 13.7 years in Finland 
(from 28.5 in 1962 to 42.2 in 2012). In 2012, Germany was the oldest population 
in Europe, with 50% of inhabitants no younger than 45, while the youngest was 
Ireland (median age of 35 years) and Turkey (29.7). Thus, the majority of European 
populations are now at least 10 years older in contrast to the youth of 50 years ago 
(Fig. 3).
Figure 2.  Proportion of the population aged 65 and over and 80 and over in selected European 
countries, 1962 and 2012
Source: own elaboration based on Eurostat (2017).
Population aging is mainly caused by the increasing life expectancy, but also 
the declining fertility is an important factor as it limits the number of children in 
the population. In many developed and developing countries, fertility rates declined 
by 50%–60% over the last 50 years, for instance, in Ireland, Austria, Slovakia, and 
Portugal (Fig. 4). Currently, in most regions the rates are far below the value of 2.1, 
which ensures the replacement of generations. In Poland, the fertility rate equals to 
1.3 and is the 13th lowest in the world (CIA, 2014).
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Figure 3. Median age in selected European countries, 1962 and 2012
Source: own elaboration based on Eurostat (2017).
Figure 4. Total fertility rate in selected European countries, 1962 and 2012
Source: own elaboration based on Eurostat (2017).
AGEING AS A FACTOR OF SOCIO-ECONOMIC COSTS, SOCIAL POLICIES, 
AND HEALTH EXPENDITURES
The ageing of a population and the changing age structure influence and 
unbalance the socio-economic situation in most countries. On the micro level, these 
processes change the structure of families and households, including their income 
and expenses and the status of caregivers and caretakers. On the macro level, more 
elderly people translate into increased public expenditures on pensions and some 
health care categories, as well as lower revenues from taxes. Retirement pensions 
are typically in the form of a guaranteed life annuity; thus, increasing longevity 
constitutes a risk to public and private financial institutions. As for the former, the 
more pensioners there are, the higher the fiscal burden on every person of productive 
age; as for the latter, the longer the time when the pension is paid, as compared 
to constant fee-paying-period of individuals at their productive age, the lower the 
future pensions. This applies also to hybrid pension systems, like the Polish one. At 
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some point, the level of pensions is bound to outweigh collected payments (current 
for the public social system or past for private accounts), which may impair the 
pension system and make pensioners require public aid.
The influence of individual longevity and population ageing on health 
expenditures is more difficult to diagnose and predict. It is generally believed that 
medical expenditures increase with age and / or with an increasing proportion of 
elderly in the population. The population ageing and increasing longevity result 
in predictions of sizeable growth in the long-term care expenditures. Both acute 
medical treatment and long-term health care expenditures rise with age mainly for 
two reasons: (1) chronic disease incidence and prevalence increase with age, and 
(2) mortality increases with age. The implications of increasing longevity for health 
care expenditures, therefore, depend critically on the future trends in morbidity, as 
expressed in the competing theories of compression or expansion of morbidity. Both 
rising life expectancy and increasing prevalence in the old age will have consequences 
for health care expenditures (Fries 1980; Stearns et al. 2007). Indeed, this tendency 
has been observed for both EU and OECD states (European Commission 2012, 
Saastamoinen and Verho 2013). However, it may not be age per se that is the root 
of the problem. The European Commission (2012) highlights that public health care 
expenses depend, among other things, on population size and structure, especially 
the age structure. The proportion of elderly in the population influences the amount 
of total and public health expenditures because older people often develop multi-
morbidity conditions that require expensive medical care. Age-related expenditure 
profiles (defined as the relationship between the age of an individual and his/her 
demand for health care) reported by the European Commission and the Economic 
Policy Committee show that expenses generally increase with a person’s age, 
especially after the age of 55. This result is confirmed in other studies, e.g. by 
Saastamoinen and Verho (2013) for Finland, who indicate that the distribution of 
health care expenditures is skewed, as only a small fraction of patients account for 
most of the costs. In Finland, 5% of the population generate over 50% of the total 
costs. The research by Alemayehu and Warner (2004) for the USA indicates that 
30% of lifetime medical expenditures per capita occur during the middle age and 
subsequent 50% in the old age. Therefore, acknowledging the rapid aging of the 
population, understanding and addressing the interaction between aging and health 
care expenses is vital for managing and plaining health care policies.
It has been also suggested that increasing life expectancy is a result of decreasing 
mortality rates at all ages, including among older people. However, in some cases, 
mortality reduction is transformed into increasing morbidity, as more years are spent 
with chronic illnesses. Historical data are not sufficient to conclusively establish 
whether longevity is generally accompanied by good health. Therefore, the EU 
forecast scenarios include the following possibilities: (a) decreasing mortality 
is accompanied by an increase in morbidity and disability (the ‘expansion of 
morbidity’ hypothesis); (b) bad health is compressed towards the latter period of life 
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at a faster pace than mortality, so people are expected to live longer while healthy 
(the ‘compression of morbidity’ hypothesis); (c) decreasing prevalence of chronic 
diseases and decreasing fatality rates from diseases lead to a longer prevalence of 
disability that counterbalance each other (the ‘dynamic equilibrium’ hypothesis) 
(European Commission 2012).
Although it is inconclusive which hypothesis reflects real trends in morbidity 
and longevity, all of them prerequisite that health care expenditures will continue 
to increase in the coming decades due to the population ageing. However, studies 
concerning this issue remain ambiguous whether age is the best and most direct 
indicator of increasing health expenses among the elderly.
As the populations of most of the developed and developing countries get older, 
the knowledge regarding the distribution of private and public health care costs 
between different age groups is crucial to forecast future health care expenditures. 
In analysing the health care expenditures of the elderly, two hypotheses are often 
mentioned: red herring and steepening, but neither has been decisively proven or 
disproven. Indeed, it is possible that both effects coexist to some extend (Gregersen 
2013). The red herring hypothesis states that health care expenditures are driven 
by time to death, not by age per se. Higher costs related to old age are in fact 
accumulated just before the death, so extended life should not increase (or even 
decrease) the overall expenditures (Zweifel et al. 1999, Werblow et al. 2007, Stearns 
and Norton 2004). For instance, in Japan the ratio of health care expenses to the 
GDP is relatively low, while life expectancy is the third longest in the world, which 
indicates a lack of influence of age on health care expenses (Sato and Fushimi 2009). 
In the USA the end-of-life care covers a large proportion of the total services funded 
by the US Medicare program, accounting for over 25% of Medicare expenditures for 
the elderly (Lubitz and Riley 1993, Riley and Lubitz 2010).
The steepening hypothesis, conversely, states that the increase in health care 
expenditures for older people is higher than for the rest of the population. Thus, 
living longer means that people are elderly for an extended period of time, which 
increases the overall costs (Buchner and Wasem 2006). Recent studies suggest that 
increasing life expectancy results in higher health care expenditures (Breyer et al. 
2014, Jagger 2000). For developed countries, an increase in the percentage of the 
elderly causes an increase in per capita health care expenditures because individual 
health care expenditures are an increasing function of age. This influence of age 
on medical expenses does not appear, however, always significant in macro-level 
analyses.
An analysis for the USA shows that elderly population had been growing faster 
than initially projected, which becomes the reason for a major debate on Social 
Security policies in the 1980s. The evidence was inconclusive (1) if the period of life 
afflicted with chronic morbidity and disability to remain relatively constant or even 
decline, or (2) if chronic morbidity and disability incidence remained unchanged, 
with life expectancy increases above 65 largely due to improved medical treatments, 
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causing an increase in the period of life spent disabled. Therefore mix strategies had 
to be introduced in the USA legislation with scheduled necessary revisions before 
large numbers of post-World War II baby boom cohorts pass the retirement age 
between the years 2011 and 2030 (Manton et al. 1997, Manton and Gu 2001).
Macro-level analyses concern predominantly public and private indirect 
expenditures. These include the costs of elderly acute and long-term care, such 
as geriatric wards and specialist medical doctors. In Poland specialist health care 
for the elderly is practically non-existent. Currently, there are approximately 270 
geriatricians (7 geriatricians per 1 million inhabitants), but only half of them work 
in this domain. In Sweden, for example, there are more than 75 geriatricians per 
1 million inhabitants, while in Slovakia and Czech Republic approximately 30 per 
1 million inhabitants. There are also very few geriatric hospital beds in Poland: 
1.5 per 100,000 inhabitants, in contrast to 75 in Sweden, 14 in Slovakia, and 6 in 
Czech Republic (Ministry of Labour and Social Policy 2013, Kokoszka-Paszkot 
2013, Derejczyk 2013). At the same time, however, the Global AgeWatch Index 
report (2013, 2014) indicates that the quality of life for the elderly in Poland has 
been improving. In 2013, Poland ranked 62nd out of 91 countries, and in 2014, it 
advanced to 32nd out of 96 states. But in the category of health status, Poland ranked 
87th in 2013 and 48th in 2014. These rankings confirm that the Polish health care 
system is not coping well with the longevity of its ageing population. In relation 
to this development, geriatrics facilities should be a leading direction for medical 
education and investment, and they should be treated as basic and fundamental, not as 
an extravagance non-affordable through the public financing. When the institutions 
and policies that should provide medical care to the elderly do not perform well, the 
burden falls on the families and households. This generates private expenditures, 
mainly out-of-pocket, but also nonmonetary costs.
Subsequently, correlation of age and medical expenses can be observed in 
studies based on microdata, except if proximity to death is taken into account due 
to the red herring effect (Dormont et al. 2006). On the micro level, per capita 
health expenditures for the elderly are higher than for younger age groups, and in 
many countries they increase at more rapid rates than those of other age groups 
(O’Connell 1996). The majority of health care expenditures are covered by public 
financing, as the health care is for the most part publicly funded; therefore, many 
countries have introduced or considered cost-containment policies that are targeted 
at lowering the amount of public funding which may transfer the burden to the 
private expenditures (Saastamoinen and Verho 2013). Studies show that despite 
many governmental attempts at health care system reforms directed at lowering 
medical expenses, households’ out-of-pocket expenditures tend to increase. This 
effect is generally stronger for lower income groups and for households with a higher 
demand for health care, that is, with elderly and / or disabled persons. This result 
is unintuitive, as expenditures generally tend to increase with higher income (Erus 
and Aktakke 2012, Matsaganis et al. 2009). Some studies also show (Guindon and 
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Contoyannis 2012) that health expenditures may also vary by region, by health and 
socio-economic status.
Rising life expectancy at birth and low fertility contribute and will contribute to 
the process of population ageing. Due to the strong positive association between age 
and health care expenditures, the current demographic trends are expected to affect 
the level of these expenses in coming years. Measuring the temporal relationships 
between socio-economic, medical, and geographic factors and the elderly’s medical 
expenditures can be useful for forecasting future values and adjusting policies 
accordingly. It is difficult to conclude whether age is the conclusive determinant of 
higher expenditures or whether it is a manifestation of other intangible factors, such 
as proximity to death, life expectancy, or health. However, because there are often 
no data on these variables, especially in household surveys, age or a more general 
age-differentiating division must be implemented (Shang and Goldman 2008).
DIRECT HEALTH CARE EXPENDITURES IN POLAND:
DATA AND STATISTICAL ANALYSIS
Since direct heath care expenses burden individual budgets of the population, 
the empirical analysis is focused on out-of-pocket expenditures of households. 
Poland’s health care system is mostly publicly funded, but almost 30% is financed 
by households through out-of-pocket expenditures, which is one of the highest rates 
of private direct funding in Europe (CSO 2013, 2012, Eurostat 2017). Services 
financed by public resources appear to patients as free of charge, while private 
indirect funding, is voluntary and predictable and, therefore, less noticeable over 
time, as opposed to direct expenditures. Out-of-pocket expenses diminish people’s 
everyday budgets and usually substitute for other expenses. These expenditures are 
often not planned or foreseeable and, therefore, are the most visible for household 
members, who often face budget constraints that may limit their accessibility to 
health care services and goods and consequently weaken their health status.
In studying the elderly’s private direct health care expenditures, datasets from 
the “Social Diagnosis 2000-2013 Objective and Subjective Quality of Life in 
Poland” survey were incorporated in the study. The survey provides a diagnosis of 
the conditions and quality of life of Poles. Data collection started in 2000 and has 
been carried out biannually (since 2003) in March-April to investigate households’ 
economic, social, medical, and cultural status. Households were selected randomly, 
on the basis of two-step sampling procedure, that is at the level of voivodships1 and 
within the class of place of residence (Czapiński and Panek 2013).




In the Social Diagnosis survey, expenditures on health care and socio-economic 
characteristics are recorded on a household level rather than on an individual level, 
which is typical for many datasets (Matsaganis et al. 2009, Erus and Aktakke 
2012). Several categories of health expenses (on a three-month basis) are defined: 
medicine and other pharmaceuticals, payments at public hospitals, gifts as a form of 
genuine gratitude for treatment, informal payments, and officially paid treatment and 
diagnosis. Combining all of the above-listed categories and calculating their average 
yearly value allows for a dataset that contains fewer zero-expenditure observations, 
than a typical dataset with individual observations (Erus and Aktakke 2012)2.
Potential explanatory variables include the following:
– last month’s real net income per person, which allows us to calculate the average 
yearly income per person,
– whether the household took loans for medical expenses,
– whether anyone was admitted to the hospital,
– whether anyone attended a private medical facility,
– voivodship of residence,
– class of place of residence (size of the residence city, town, village by the number 
of population).
As there is no information concerning the age of each household member, the 
households were divided based on the main income source. Households living off 
pensions are treated as those of the elderly, and the remainder are the control group. 
If a household’s income is earned mostly by pensioners, it is assumed that the 
majority of the expenditures are made by them as well.
The research is carried out to determine the average yearly total health care 
expenditures of a household expressed in Polish zlotys (PLN)3 and their potential 
determinants over time, regions, and income sources (pensions vs. otherwise). The 
representative samples of households for 2003 and 2013 from the Social Diagnosis 
survey were divided into four groups by year and income source: (1) pensioners 
(elderly) in 2003; (2) non-pensioners (non-elderly) in 2003; (3) pensioners (elderly) 
in 2013; (4) non-pensioners (non-elderly) in 2013.
First, a statistical analysis is carried out to determine the spatial distribution 
of expenditures and income, as well as their dynamics over time. This research 
includes statistical inferences to determine whether expenditures, income, and 
household structure were the same for the pensioner and non-pensioner groups. To 
analyse whether households had limited demand for pharmaceuticals4 due to budget 
2 Medical expenses include pharmaceuticals (which constitute the highest share of total expenses), 
ambulatory, hospital, and informal expenses. Since non-pharmaceutical expenses have very unusual 
distributions, with 90–98% observations with null costs, it is difficult to analyse and model them sepa-
rately;, therefore, the aggregated expenses are introduced.
3 1 USD = 3. 8 PLN and € 1 = 4.2 PLN (06.07.2015).
4 In the Social Diagnosis survey database there is only information on “could not buy medicine due 
to insufficient funds”, there is no analogical variable for others groups of medical expenses.
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constraint, fraction tests were performed. In 2003 the group of pensioners and non-
pensioners were similar (no statistically significant differences, p = 0.47) in the 
aspect of the share of households with limited access to medical care. However, 
a one-fraction test confirmed that the proportion of the households with limited 
access was very high, in fact higher than 30% for the pensioner (p = 0.003) and 
non-pensioners (p = 0.000). In 2013 the percentage of households with not sufficient 
income to buy medical drugs declined. For elderly and non-elderly the share was 
significantly lower in 2013 than in 2003 (for both groups p = 0.000). Overall, in 
2013 the proportions of limited medicine access were higher than 15% (p = 0.000) 
and lower than 20% (p = 0.000) for non-pensioners and more than 15% (p = 0.000) 
and most likely around 20% (not lower than 20%, p = 0.19) for pensioners. However, 
a two-fraction test for 2013 suggested that elderly households significantly more 
often had limited access than non-elderly ones (p = 0.000). In spite of the fact that 
the fraction of households with insufficient funds to buy all necessary medical drugs 
declined over the decade, the inequality in drug access between non-elderly and 
elderly increased.
Total health care expenses of households varied over time, region, and income 
source group. In 2003, pensioners spent annually from 316 PPP USD5 in Podlaskie 
to 720 PPP USD in Podkarpackie, which is from 8 to 20% of an average real net 
income per capita in a pensioner’s household. In the same year, non-pensioners had 
medical expenditures from 225 to 401 PPP USD, which is by half lower, than those 
of the elderly. This amount was 6–9% of the yearly real net income per capita of 
the control group households in each province. In addition, the share of health care 
expenditures in income was also lower for the non-elderly, despite the fact that the 
pensioners’ incomes were generally higher than those of the control group.
The regional distribution of health care expenditures appears to be irregular. The 
Mazowieckie province, which is the largest voivodship and includes the capital city 
of Warsaw, was among the three provinces with highest expenses in both groups of 
households. The distribution in 2013 differed from that registered 10 years before, 
but again, there is no clear spatial pattern. The pensioners’ expenditures increased 
to 626–994 PPP USD annually, which represents 9–12% of the real net income 
per capita in each province. For non-pensioners, health expenditures ranged from 
229 PPP USD to 630 PPP USD, that is 3–9% of an average province’s yearly real 
net income per capita. Again, Mazowieckie province was among the regions with 
the highest expenditures (Fig. 5).
5 All current price values in Polish zlotys (PLN) were changed to real prices as of 2013 and PPS 
USD (purchase power standard) using the World Bank PPP indicator for 2013.
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Figure 5.  Households’ average annual health care expenditures for pensioners and non-pensioners 






Source: own elaboration based on Czapinski (1998).
Figure 5 indicates that pensioners spend more on health care (as an absolute 
value or as a ratio to income, where both the expenditures and income is calculated 
per household member) than the control group. To confirm this result, a series 
of tests was performed. First, the average income per household member turned 
out to be higher for pensioners than non-pensioners both in 2003 and 2013 
for Poland (p = 0.0000) and for each province (p < 0.01) except for 2003 in 
Podkarpackie (p = 0.02) and 2013 in Lubuskie (0 = 0.02), Podlaskie (p = 0.1), and 
Zachodniopomorskie (p = 0.08), which shows differences at the significance level 
of 10%, and Malopolskie (p = 0.3) and Mazowieckie (p = 0.6), which shows no 
statistically significant difference6. We also tested whether the number of household 
members was equal in both groups. In general, non-elderly households had more 
6 In each case, the equality of the variances was verified and dismissed (p < 0.000). A mean test 
was performed accordingly.
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members than elderly households in 2003 and 2013 in Poland (p = 0.000)7. Therefore, 
in elderly households the income is divided by fewer members. However, even 
with higher income, the elderly spent relatively more by 2–3 percentage points. 
We also tested whether the absolute value of the expenditures on health care was 
indeed different for both types of households. In 2003 in Poland (p = 0.000) and 
in 10 provinces (p < 0.01), pensioners spent significantly more than non-elderly 
persons. In Malopolskie (p = 0.01), Opolskie (p = 0.08), Podkarpackie (p = 0.04), 
Swietokrzyskie (p = 0,02), and Warminsko-mazurskie (p = 0.03), the same 
conclusion can be drawn with a significance level of 10%. The only exception is 
Wielkopolskie (p = 0.8), which shows no difference. In 2013, pensioner households 
had higher health care expenses than the control group for Poland (p = 0.000) and 
in 13 provinces (p < 0.01) with the exception of Kujawsko-Pomorskie (p = 0.02), 
Podkarpackie (p = 0.02), and Pomorskie (p = 0.1), which can be included if the 
significance level is 10%8.
Figure 6.  Medical expenditures of pensioners in relation to expenditures of non-pensioners by 
voivodships, 2013
Source: own elaboration based on Czapinski (1998).
Therefore, it has been demonstrated that health care expenditures are generally 
higher for pensioner households than for non-pensioner households. The difference 
is the largest in the northern and eastern provinces, where the elderly spend twice as 
much as the control group. In the central provinces, where the ratio of elderly to non-
elderly expenses is the lowest, there is still a difference of 35% (Fig. 6). In addition, 
medical expenses (in absolute real values and relative to the income) increased in 
7 The equality of the variances was verified and dismissed (p < 0.000) for both years. A mean test 
was performed accordingly.




2013 as compared to 2003. The total value of expenditures of the elderly over the 
decade in question increased from 12% to 150%, by province, compared with 2003. 
The fastest increase was observed in the southeast of Poland. This effect is slightly 
slower for non-pensioner households (Fig. 7).
Figure 7. Ratio of Pensioners medical expenditures in 2013 to value in 2003
Source: own elaboration based on Czapinski (1998).
The statistical analysis suggests that the members of elderly and non-elderly 
households behave differently concerning health care expenditures. The changes 
over time also differ for the two groups. These expenses, their increase over time 
and the ratio of the medical expenditures to income for the pensioners’ to non-
pensioners vary by Polish region and do not necessarily correlate with the spatial 
distribution of households’ income. Therefore, it is possible that the determinants 
of health care expenditures and the significance of their influence are different for 
the elderly than for the rest of the population. Therefore, an econometric model was 
introduced to verify this hypothesis.
MICROECONOMETRIC MODEL
OF POLISH HOUSEHOLDS’ DIRECT HEALTH CARE EXPENDITURES
A microeconometric model of the same general structure was specified and 
estimated for each of the four groups. This approach should permit us to define 
similarities and differences between elderly households and the control group, as well 
as possible changes over time in the significance and strength of the determinants of 
out-of-pocket health care expenditures. Many approaches assume that expenditures 
are exponential and/or log-linear function of the explanatory variables. This approach 
seems to be in particular appropriate when considering total expenditures on health 
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care, as opposed to selected category of them (Hill and Miller 2010)9. Therefore, 
the considered model is a power-exponential function that is specified as follows:
 ME I e
i i
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a a a a a a a f+ + + ++ +
==
//  (1)
where MEi is the real (in 2013 prices) yearly ‘out-of-pocket’ expenditure on health 
care per person, Ii is the real (in 2013 prices) yearly household income per person, 
Li is a binary variable equal to 1 if the household took a loan for medical expenses 
(and 0 otherwise), Hi is a binary variable equal to 1 if anyone in the household was 
admitted to hospital, PFi is a binary variable equal to 1 if anyone in the household 
attended private medical facility, Pji is a binary variable equal to 1 if the household 
is located in the jth province, Cki is a binary variables equal to 1 if the household is 
located in the kth city size, and εi is the random error.
The parameters of each of the four models – Pensioners 2003 (P03) with 998 
observations, Non-pensioners 2003 (NP03) with 2,964 observations, Pensioners 
2013 (P13) with 3,827 observations, and Non-pensioners 2013 (NP13) with 8,528 
observations, were estimated independently, and the set of explanatory variables 
was chosen from the group of significant variables in order to fit the data best. 
The estimations were performed using the STATA MP software and GMM robust 
estimators (White-corrected standard errors). This method should adjust for the 
strong possibility of heterogeneity and heteroskedasticity of the micro data.
FINANCIAL RESOURCES
Financial resources appeared to be an important determinant of medical expenses 
(Table 1). The influence of income, which can be perceived as income elasticity of 
demand for medical goods and services, was the most important factor among all 
significant variables. In 2003, an increase in income per capita by 1% would cause 
an increase in medical expenditures by almost 0.8% for pensioners and 0.6% for 
non-pensioners. In 2013, the same increase would be 0.6% and 0.5%, respectively. 
This result suggests that the income effect was stronger for the elderly than for the 
control group and it decreased over time for the whole population.
In households that have taken a loan for medical expenses, these expenditures 
tend to be higher than in those without loans. For the pensioners, expenditures were 
higher by 42% in 2003 and 21% in 2013, while for non-pensioners expenditures were 
higher by 61% in both 2003 and 2013. The influence of medical loans was much 
stronger for the control group than for the elderly and stable over time for the control 
group, while it declined for the elderly. The variable indicating whether households 
9 Modeling separate categories of expenses would require using other microeconometric approaches, 
such as two-part model or truncated models to estimate expenditure value or, if it would be impossible, 
modeling the probability of expenses occurrence by bi- and multinomial models (Cameron and Trivedi 
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took loans for medical purposes may inform us about substantial expenditures that 
could not have been covered by current income or savings, and indirectly, about 
serious and unforeseen health problems. Therefore, the large difference between 
level of expenditures in households with and without loans seems to be justified. 
The impact may be smaller for the elderly, as many of their health problems are 
long-term and predictable. It is also possible that even if pensioners cannot cover 
their medical expenses from income and savings, they may be less likely to take 
a loan because their problem will be prolonged and will simply generate more and 
more expenditures. Therefore, a single loan is not a viable solution to this problem.
STAY IN HOSPITAL OR PRIVATE MEDICAL INSTITUTION
The dataset does not contain sufficient information on household members’ state 
of health; therefore, in order to describe the use of health care facilities we needed to 
introduce the realized demand for medical assistance. If any member of a household 
was admitted to hospital, private direct medical expenditures were higher by 49% 
for pensioners and by 45% for non-pensioners in 2003 (as compared to a household 
where no one was admitted to hospital), while in 2013 higher by 37% for pensioners 
and 46% for non-pensioners. It is conceivable, although impossible to verify, that 
some part of these extra expenses is due to gifts offered to medical personnel as 
a form of genuine gratitude for treatment or informal payments. It is also likely that 
a stay in hospital corresponds to general deterioration in one’s state of health, which 
subsequently increases medical expenses on drugs, doctor visits, and/or medical 
procedures.
Attending private medical institutions, including private specialist doctors’ 
offices, directly influences the level of medical expenses. Although most medical 
procedures are available free of charge, long waiting lists for medical public services 
and the requirement of having a referral to specialist facilities make people turn to 
private health care. The latter, however, do not provide all types of medical care 
and their prices are not fixed. Thus, if people use private health care, their medical 
expenditures are considerably higher. For the elderly, the difference was 47% in 
2003 and 49% in 2013, while for the control group, the difference was 65% in 2003 
and 55% in 2013 (as compared to those who did not use private facilities). The 
expenses increased more in the case of non-pensioners as compared to pensioners, 
but for the former this effect declined over time, while for the latter little change 
over time was observed.
SPATIAL HETEROGENEITY
In our model regional adherence was represented by binary variables for the 
provinces and the size of location (by number of inhabitants). In 2003, there was 
no regional effect based on provinces, and the size of location was relevant for 
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pensioners only in the case of the five largest cities (with no less than 500,000 
inhabitants): Warsaw (in Mazowieckie voivodship), Cracow (Malopolskie), Lodz 
(Lodzkie), Wroclaw (Dolnoslaskie), and Poznan (Wielkopolskie). In these cities, the 
elderly had average medical expenses that were by 30% higher than in the rest of the 
country. This difference may be due to the increased opportunity to attend private 
doctors and health care institutions, which generates more direct expenditures.
In 2013, medical expenditures were significantly lower in some provinces. 
This effect was in particular strong for both pensioners and non-pensioners in 
Warminsko-mazurskie province, where expenses were lower by 30% and 40%, 
respectively. This north-eastern region lacks major cities and economic centres, and 
it has the highest unemployment rate in Poland, equalling to 21.6% in 2013 as 
compared to the country’s average rate of 13.4%. It also has one of the lowest level 
of GDP per capita, at 15,789.5 PPP USD, as compared to Poland’s overall GDP per 
capita of 22,105.3 PPP USD in 2012 (CSO 2015). Similar differences in other regions 
were not substantial. While the non-elderly had lower medical expenses relatively 
rarely, the elderly living in Mazowieckie and Opolskie spent more than anywhere 
else, by 12% and 18%, respectively. Mazowieckie is the largest province in Poland, 
both in land and inhabitants, and it includes Warsaw, which is the largest economic 
centre in the country. In 2013 the province had the second-lowest unemployment 
rate of 11% and the highest GDP per capita – 35,157.9 PPP USD. It is difficult to 
explain however, why in Opolskie the elderly pay more for health care than in any 
other province.
In the case of pensioners, the size of the city they live in is significant. People 
in middle-sized cities of 100,000–500,000 inhabitants spent 14%–16% more than 
those living elsewhere.
In general, over the last decade, regional heterogeneity increased, most likely 
due to health care system reforms, the system’s inefficiency, and the growing supply 
of private medical institutions and over-the-counter pharmaceuticals. These factors 
are diverse over time and groups, which makes it difficult to predict their values 
in the future through this analysis. Nevertheless, the geographic component plays 
a significant role in the level of private direct medical expenditures, and as such it 
cannot be neglected.
CONCLUSIONS
Longevity, expressed directly as long individual lifespan and indirectly as 
increasing life expectancy is a demographic fact. People both in developed and 
developing countries live longer than few decades ago. What is more, the shares 
of elderly, old, and very old in a population are systematically increasing. These 
demographic changes influence many aspects of life, such as the quality of life, 
family social structure, market targeting, pension systems, but also health care 
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system and health care expenditures. Yet, health economists do not fully understand 
the mechanism of causality between longevity, public health, health care system, and 
health care expenditures. Therefore, there are numerous theories explaining these 
relationships, but some of them remain contradictory, and some – complementary. 
Large body of empirical evidence indicates that, in general, longevity and population 
aging go hand in hand with increasing health care expenses (total, public and 
private, direct and indirect) and, specifically, increasing expenses associated with 
the elderly and the end-of-life. This is a strong argument based on the literature 
review and the empirical evidence for confirming our first hypothesis (“the medical 
expenditures increase with longevity”). Financing health care creates a constraint 
for any health care system. In Poland the system has not been well adjusted to the 
changing demographic structure. We are lacking geriatric wards, beds, specialists, 
and equipment. This deficiency will become more and more noticeable in the coming 
years if no policy improvements are introduced and successfully implemented. In 
the meantime, part of the unmet demand for health care services is substituted by 
private direct expenditures of households, mainly on pharmaceuticals and private 
medical consultations.
The cross-sectional analysis over years 2003 and 2013 for representative 
households’ samples for Poland gives some intuitively logical conclusions and some 
surprising ones. Firstly, pensioners, even having higher income per capita, spend 
more on health care than the control group:
– relatively (share of expenses in income) by 2–3 percentage points,
– in absolute values by 35% (central provinces) to 180% (the northern and eastern 
provinces),
– the real value of expenses increase over time for all households, but slightly 
faster for the elderly (by 12% to 148% over 10 years) than non-elderly (from 9% 
to 117%).
Moreover, although the share of households that could not afford buying medical 
drugs decreased over the decade from more than 30% for elderly and non-elderly in 
2003 to 15–20% in 2013, which is very positive change, economic inequalities of 
access to medical services were absent in 2003, and visible in 2013. It means that 
more elderly than non-elderly households had a difficulty with affording drugs from 
out-of-pocket funding. These conclusions support the second hypothesis, that elderly 
in fact spend more on health than non-elderly, but also, despite higher income, their 
needs exceeded financial resources and were more often unmet. Some actions were 
introduced in order to lower the expenditures on medical drugs, however, most 
policies are underdeveloped and change with each government.
It reference to the last hypothesis concerning determinants of private direct 
medical expenses, the microeconometric approach indicates that most factors are 
common for elderly and non-elderly, but the strength of their influence, and their 
changes over time vary between groups. The main constraint on households’ health 
care expenditures is income for both the elderly and the non-elderly, but the income 
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elasticity is higher for the elderly by 0.1–0.2 percentage points. The elderly have 
a weaker propensity (than non-elderly) of:
– taking medical loans, as their expenses are usually long-term and singular finan-
ce injection is a very short-term solution,
– using private health care, as they are more often in need of regular, long-term 
medical assistance, whereas long-term private medical services are not common 
or cheap in Poland,
– being hospitalized, as hospitalization is more often due to accidents and acute 
medical aid, whereas the elderly suffer mostly from long-term diseases.
Overall, the budget limitation is the key factor of out-of-pocket expenditures 
for all age groups. If a household’s income is low, the requirement to prioritize 
needs and expenses may eliminate some vital medical drugs or procedures in favour 
of basic needs. Therefore, it is crucial to provide the elderly and the poor with 
adequate and specialized health care products and services. The elderly constitute 
a unique and expanding group of citizens, due to the demographic phenomena 
of longevity and population aging, with growing medical needs and insufficient 
financial resources. Polish public health care system is not prepared to cope with 
the high medical demand of the elderly. Therefore, part of this demand is satisfied 
by private medical services, which for many is not affordable. This causes a spiral 
of: lacking medical services – deteriorating public health (of elderly and the total 
population) – increased demand for health care – lacking funding – lacking medical 
services. Longevity and population aging must be directly addressed in the social 
policy, in order to improve quality of life, public health, and social conditions. This 
need highlights a new direction for the development of Poland’s health care system. 
Otherwise, longevity may be a luxury that not everyone can afford.
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LONGEVITY – CAN WE AFFORD IT?
THE PROBLEM OF HOUSEHOLDS’ DIRECT 
HEALTH CARE EXPENDITURES IN POLAND
ABSTRACT
Longevity can be perceived as increasing life expectancy in a population or as 
the long lifespan of an individual. Longer lifespans and decreasing fertility rates in 
many countries will cause societies to rapidly grow old. This paper is an attempt to 
define the determinants of the ‘out-of-pocket’ medical expenditures of the elderly. In 
this research statistical tests and micro-econometric modelling were carried out on 
a sample of the Polish population. The results of the analysis indicate that the elderly 
with their elevated needs for medical assistance spent more on the health care, than 
the rest of population (in the absolute value and in relation to income) and that their 
expenditures are constantly increasing. The main limitation to households’ health 
care expenditures is the income, which suggests that there may be an unrealized 
demand for medical services and products, especially medical drugs that cannot be 
obtained entirely free of charge. This highlights a new direction for the development 
of Poland’s health care policy; otherwise, longevity may be a luxury that not 
everyone can afford.
Keywords: longevity, health expenditures, Polish health care, social policy, 
health econometrics
